Coya Therapeutics, Inc. (NASDAQ:COYA) announced blood biomarker data from an investigator-initiated, 21-week, double-blind, ...

Coya Therapeutics (COYA) announced encouraging blood biomarker data from an investigator-initiated, 21-week, double-blind, placebo-controlled, ...

Omnicell delivers strong fourth quarter financial results. Results exceed previously issued full year guidance for bookings, total revenues, and non-GAAP EBITDA. FORT WORTH, Texas ...

As scientists unravel how sleep benefits the body, a study in mice is highlighting the potential pitfalls of using Ambien and other sleeping pills.

What has puzzled researchers and philosophers for many centuries is the ‘why’ of sleep, along with the ‘how’. We human animals know from experience that we need to sleep, ...

Managers see mixed opportunities in emerging markets and a broadening opportunity set for small caps across global markets.

In a bid to revolutionize Alzheimer’s detection, scientists have examined the brain’s neurovascular unit. The research ...

Incyte Corporation INCY is scheduled to report fourth-quarter and full-year 2024 results on Feb. 10, before the opening bell.

Model-based approaches confer benefits at all stages of the drug life-cycle, from identifying the first dose to be used in children, to clinical trial design, and optimising the dosing regimens of ...

Hence, researchers often simulate the brain as a network of coupled neural masses, each described by a mean-field model. These models capture the essential features of neuronal populations while ...

probably because of the conflict between mitogenic pressure and the inability to proceed through the cell cycle 21. The different cellular context might account for the different effects of HMGA1 ...

Fluid dynamics is the study of the motion of liquids, gases and plasmas. Flow is dependent on the intrinsic properties of the matter itself, such as compressibility, viscosity and density. Example ...